Yahoo Web Search

  1. U.S. stocks were set to open higher on Monday, as mixed global economic data lifted expectations of monetary stimulus from central banks, including the U.S. Federal Reserve. Markets were on ...

  2. An Alzheimer's vaccine developed by a privately held Slovakian biotech firm showed early signs of efficacy in a mid-stage trial, a rare step forward in the fight against the brain-wasting disease ...

  3. Leaner Pfizer Positioned to Boost R&D Output

    GuruFocus.com via Yahoo FinanceSep 11 19:50 PM

    If it's true that busy hands are happy hands, then the management team at Pfizer Inc. (NYSE:PFE) must be ecstatic. Agreed to spin off Upjohn, the manufacturer of Pfizer's drugs that no longer ...

  4. Pfizer's Pneumococcal Vaccine Shows Potential in Infants

    Zacks via Yahoo FinanceSep 10 22:06 PM

    Pfizer Inc. PFE announced encouraging data from a phase II study evaluating its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, in healthy infants. The proof-of-concept ...

  5. Gilead Tops List of Most Innovative Drug Companies

    GuruFocus.com via Yahoo FinanceSep 12 21:46 PM

    Gilead Sciences Inc. (NASDAQ:GILD) tops the list of companies on the 2019 Pharmaceutical Innovation Index issued by IDEA Pharma, a U.K-based consulting firm that helps members of the industry ...

  6. Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally

    Zacks via Yahoo FinanceSep 11 13:46 PM

    Lexicon Pharmaceuticals, Inc. LXRX announced that it will regain re-gain global rights to diabetes drug, Zynquista (sotagliflozin), and will receive $260 million from Sanofi SNY per the terms ...

  7. Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another ...

  8. The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon therapy that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday ...

  9. The settlement could be valued at up to $12 billion, they said, which would make it the largest such settlement in U.S. pharmaceutical history. * Merck & Co $4.85 billion, 2007 - Three years ...

  1. Ads
    related to Eli Lilly